当前位置:主页 > 医学论文 > 影像医学论文 >

全身照射螺旋断层放疗剂量验证与分析

发布时间:2019-06-21 13:48
【摘要】:目的初步探讨Arc check调强剂量验证系统在全身照射(TBI)螺旋断层放射治疗剂量验证中的意义。方法将9例TBI患者的螺旋断层放疗计划移植到Arc check调强剂量验证系统和螺旋断层放疗系统标配的Cheese Phantom二维剂量验证系统上进行点剂量及γ通过率的剂量验证。用Pearson相关分析法检验两个验证系统点剂量与γ通过率的相关性,并用配对t检验方法检验其优劣性。结果 Arc check剂量验证系统和Cheese Phantom二维剂量验证系统的点剂量测量值与计算结果的平均误差分别为1.5%和1.7%。采用3%/3 mm标准的平均γ通过率分别为97.7%和95.2%。两个验证系统点剂量的R2值为0.896(P0.01),γ通过率的R2值为0.832(P0.01),且两个验证系统的验证结果呈正相关。但两个验证系统的验证结果比较差异无统计学意义(P=0.132,P=0.085)。结论 Arc check能很好地用于TBI螺旋断层放疗剂量验证工作,为以后的TBI剂量验证提供准确的临床质量保证。
[Abstract]:Objective to investigate the significance of Arc check intensity modulation dose verification system in the dose verification of whole body irradiation (TBI) spiral tomography radiotherapy. Methods the spiral tomographic radiotherapy plans of 9 patients with TBI were transferred to the Arc check intensity modulation dose verification system and the Cheese Phantom two-dimensional dose verification system of spiral tomographic radiotherapy system for the dose verification of point dose and gamma pass rate. Pearson correlation analysis was used to test the correlation between dose and gamma pass rate of the two verification systems, and pairing t test was used to test their advantages and disadvantages. Results the average errors between the point dosimetry values and the calculated results of Arc check dose verification system and Cheese Phantom two-dimensional dose verification system were 1.5% and 1.7%, respectively. The average gamma passing rates using 3% 鈮,

本文编号:2504123

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fangshe/2504123.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户bc006***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com